Kenneth Minett, DO
Emergency Medicine · Parsippany, NJNPI 1477780187
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $796,296 of the $797,132 with a category attached, or 99.9%. AbbVie accounts for 99.9% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $252,844, more than ten times the $168 reported in 2019. Among emergency medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 262 payments — averaging $3042.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$796K
- AstraZeneca$426
- Johnson & Johnson$144
- Gilead$125
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$15
- Portola Pharmaceuticals, LLC$15
- plus $14 from 1 others
What the payments were for
- Consulting fees$796,296100%
- Food & beverage$8360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 247 | $796,393 |
| AstraZeneca | 8 | $426 |
| Johnson & Johnson | 3 | $144 |
| Gilead | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$797,132 in reported general payments places this provider in the 95th percentile of 1,505 emergency medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 25 | $369 |
| Cephalexin | 13 | $105 |
| Methocarbamol | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Parsippany
- Sreedar RajaParsippany$2K
- Michael GouldSomerville$2.8M
- Marc MilanoBerkeley Heights$392K
- Gerardo ChiricoloToms River$161K
- Hardik SoniDenville$159K
- Lindsay van PeltPompton Plains$146K
- Joseph TestaWayne$100K
- Chinwe OgedegbeEast Orange$82K
- John FontanettaBelleville$59K
- Adam HennesseyCamden$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.